Literature DB >> 23477506

The effects of synbiotic supplementation on some cardio-metabolic risk factors in overweight and obese children: a randomized triple-masked controlled trial.

Morteza Safavi1, Sanam Farajian, Roya Kelishadi, Maryam Mirlohi, Mahin Hashemipour.   

Abstract

Recent studies have suggested some beneficial effects of probiotics on controlling excess weight in adults; such experience is limited in the pediatric age group. This study aimed to assess the anti-obesity and lipid-lowering effects of a synbiotic supplement among children and adolescents. We conducted a randomized triple-masked controlled trial among 70 participants aged 6-18 years with body mass index (BMI) equal or higher than 85th percentile. They were randomly assigned to two groups of equal number to receive synbiotic or placebo for 8 weeks. At the end of the trial, decrease in BMI Z-score, waist circumference, and waist-to-hip ratio were significantly higher in the synbiotic group than in the placebo group. Likewise, synbiotic group had significant decrease in serum triglycerides, total- and low density lipoprotein-cholesterol levels. The beneficial effects of a synbiotic supplement on controlling excess weight and some cardio-metabolic risk factors among children and adolescents can be considered in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23477506     DOI: 10.3109/09637486.2013.775224

Source DB:  PubMed          Journal:  Int J Food Sci Nutr        ISSN: 0963-7486            Impact factor:   3.833


  25 in total

1.  A randomized double-blind placebo controlled pilot study of probiotics in adolescents with severe obesity.

Authors:  Arushi Verma; Maria T Nelson; William R DePaolo; Christiane Hampe; Christian L Roth
Journal:  J Diabetes Metab Disord       Date:  2021-08-08

Review 2.  The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD).

Authors:  Zahra Safari; Philippe Gérard
Journal:  Cell Mol Life Sci       Date:  2019-01-25       Impact factor: 9.207

Review 3.  The infant gut microbiome: evidence for obesity risk and dietary intervention.

Authors:  Petya T Koleva; Sarah L Bridgman; Anita L Kozyrskyj
Journal:  Nutrients       Date:  2015-03-31       Impact factor: 5.717

Review 4.  The overarching influence of the gut microbiome on end-organ function: the role of live probiotic cultures.

Authors:  Luis Vitetta; Rachel Manuel; Joyce Yusi Zhou; Anthony W Linnane; Sean Hall; Samantha Coulson
Journal:  Pharmaceuticals (Basel)       Date:  2014-09-19

5.  Effects of synbiotics on treatment of children with failure to thrive: A triple blind placebo-controlled trial.

Authors:  Fatemeh Famouri; Abolfazl Khoshdel; Arghavan Golshani; Soleiman Kheiri; Hossein Saneian; Roya Kelishadi
Journal:  J Res Med Sci       Date:  2014-11       Impact factor: 1.852

Review 6.  Childhood obesity: a role for gut microbiota?

Authors:  Marina Sanchez; Shirin Panahi; Angelo Tremblay
Journal:  Int J Environ Res Public Health       Date:  2014-12-23       Impact factor: 3.390

Review 7.  Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials.

Authors:  Maria Jose Sáez-Lara; Candido Robles-Sanchez; Francisco Javier Ruiz-Ojeda; Julio Plaza-Diaz; Angel Gil
Journal:  Int J Mol Sci       Date:  2016-06-13       Impact factor: 5.923

Review 8.  The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood.

Authors:  John Slattery; Derrick F MacFabe; Richard E Frye
Journal:  Clin Med Insights Pediatr       Date:  2016-10-09

Review 9.  Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.

Authors:  Emma Mead; Tamara Brown; Karen Rees; Liane B Azevedo; Victoria Whittaker; Dan Jones; Joan Olajide; Giulia M Mainardi; Eva Corpeleijn; Claire O'Malley; Elizabeth Beardsmore; Lena Al-Khudairy; Louise Baur; Maria-Inti Metzendorf; Alessandro Demaio; Louisa J Ells
Journal:  Cochrane Database Syst Rev       Date:  2017-06-22

10.  Pharmacotherapy of pediatric metabolic syndrome.

Authors:  Roya Kelishadi; Fahimeh Jamshidi
Journal:  J Res Pharm Pract       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.